*These authors contributed equally to this work. Dr. Kuzmin is a physics resident, Department of Radiation Oncology, Cleveland Clinic, OH. Ms. Gidwani is a graduate student, Department of Translational Hematology Oncology Research, Cleveland Clinic. Dr. Ma is a physics resident, Department of Radiation Oncology, Cleveland Clinic. Dr. Zhuang is a physicist, Department of Radiation Oncology, Cleveland Clinic. Dr. Abazeed is the director, Center for Precision Radiotherapy, Department of Radiation Oncology, and assistant professor, Cleveland Clinic Lerner College of Medicine. Disclosure: None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere. Dr. Abazeed reports grant support from Siemens Healthcare, Malvern, PA.
Dr. Beydoun is a PGY4 resident, Section of Radiation Oncology, and Dr. Cher is professor and chair, Department of Urology, Karmanos Cancer Institute, Detroit, MI. Dr. Weinberg is an attending radiation oncologist, Department of Radiation Oncology, Pardee Cancer Center, Hendersonville, NC. Dr. Hurst is an attending radiation oncologist, Department of Radiation Oncology, Loyola University Medical Center, IL. Dr. Khoury is section chief, Section of Pathology; Dr. Ahmed is section chief, Section of Medical Oncology; Mr. Kasza is a therapeutic medical physicist, Section of Radiation Oncology; and Dr. Tang is an attending radiation oncologist, Section of Radiation Oncology, John D. Dingell Veterans Affairs Medical Center, Detroit, MI.
Disclosure: The authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere.
Prepared by Dr. Joshi, Dr. Radhakrishnan, Dr. Rotem, and Dr. Bowers while at the Division of Vascular/Interventional Radiology,Medical College of Georgia, Augusta, GA.
Mr. Yankey is a fourth-year medical student at Lewis Katz School of Medicine, Temple University, Philadelphia, PA. Dr. Anaokar is assistant professor of radiology, Department of Diagnostic Imaging, Fox Chase Cancer Center, Philadelphia, PA. Also at Fox Chase, Dr. Meyer is associate professor of radiation oncology, Department of Radiation Oncology. Disclosure: The authors have no conflicts of interest to disclose, and no part of this article has been previously published elsewhere. Acknowledgements: This publication was supported by grant number P30 CA006927 from the National Cancer Institute, NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.
Dr. Abu-Gheida is a radiation oncology fellow, Dr. Fleming is a first-year resident, Dr. Mian is associate staff, Dr. Tendulkar is the clinical director and residency program director, and Dr. Ciezki is a staff physician, Cleveland Clinic, Taussig Cancer Institute, Department of Radiation Oncology, Cleveland, OH. Dr. Ramia is a second-year resident at the American University of Beirut Medical Center, Naef K. Basile Cancer Institute, Department of Radiation Oncology, Beirut, Lebanon. The authors would like to thank Chirag Shah, MD, and Salim Balik, PhD, for their contributions.
Mr. Chowdhury is a medical student at Geisinger Commonwealth School of Medicine, Scranton, PA. Dr. Gandhidasan is a fellow at the Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, Dr. Parsai and Dr. Kotecha are resident physicians at the Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, and Dr. Suh is a professor and the chairman of the Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH.
Conflicts of interest: Dr. Suh: consultant and research support from Varian Medical Systems, Palo Alto, CA; honorarium from Philips Medical Systems, Amsterdam, The Netherlands.